Condition
Anal Squamous Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Anal Squamous Cell Carcinoma clinical trials that are recruiting, at sites in 5 countries (most in United States (4), Australia (1), Canada (1)). 1 was first registered in the last 30 days. By phase: Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1New in 30 days
- 5Countries
Newest Anal Squamous Cell Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Retifanlimab after chemoradiation for anal cancer | Phase 2 | Basking Ridge, New Jersey and 6 other locations | Recruiting | Nov 10, 2026 |
| EVOLVE104 for advanced bladder and other squamous cell cancers | Phase 1 | Duarte, California and 15 other locations | Recruiting | Oct 15, 2025 |
| High resolution anal examination for HPV and anal cancer detection | — | Jette | Recruiting | Nov 20, 2024 |
| MR-guided radiation therapy for anal cancer with tailored treatment | Phase 2 | Pittsburgh, Pennsylvania and 4 other locations | Recruiting | Sep 22, 2023 |
| Adaptive radiation therapy for anal cancer | — | New York, New York | Recruiting | May 1, 2023 |
| Daily online adaptive radiotherapy for anal cancer | — | Herlev | Recruiting | Jun 30, 2022 |
All recruiting trials (6)
-
Retifanlimab after chemoradiation for anal cancer
This study tests whether retifanlimab can help people with anal squamous cell carcinoma who have completed chemoradiation and still have residual disease.
-
EVOLVE104 for advanced bladder and other squamous cell cancers
This will try EVOLVE104, an experimental drug, in adults with advanced or metastatic bladder or other squamous cell cancers who have already tried or cannot take standard treatments.
-
High resolution anal examination for HPV and anal cancer detection
This study is testing how well high-resolution anal exams can help find high-risk HPV and anal cancer in people who are more likely to have these issues.
-
MR-guided radiation therapy for anal cancer with tailored treatment
This study is testing a personalized radiation therapy approach for patients with anal cancer to see if adjusting treatment based on their individual risk levels and biomarkers can improve their outcomes.
-
Adaptive radiation therapy for anal cancer
This study is testing a new way of giving radiation therapy that changes daily based on how the tumor responds, to see if it helps people with advanced anal cancer while protecting healthy tissue.
-
Daily online adaptive radiotherapy for anal cancer
This study is testing if daily online adaptive radiotherapy can help people with anal cancer experience less stomach problems compared to standard radiation treatment.
Related topics
Quick answers
How many Anal Squamous Cell Carcinoma clinical trials are recruiting right now?
6, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (4 trials), Australia (1 trial), Canada (1 trial), Belgium (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.